Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs targeted at expanding the horizons of cytokine-based immunotherapy, especially for cancers where cure alternatives remain limited. Use the links below to learn extra about our portfolio of cytokine-based immunotherapy candidates. Check out Our Pipeline https://financefeeds.com/usdchf-technical-analysis-report-14-march-2025/